Impact-Driven Strategies for Optimizing Inhaled Therapy Adherence in COPD: The OPTIMO Delphi Consensus

以影响为导向的策略优化慢性阻塞性肺疾病吸入治疗依从性:OPTIMO 德尔菲共识

阅读:4

Abstract

INTRODUCTION: Medication adherence is an important challenge in the management of COPD, with poor adherence negatively impacting symptom control, disease progression, and healthcare resource utilization. OBJETIVES: This study aimed to achieve multidisciplinary consensus on practical, prioritized interventions for improving adherence and clinical results in stable COPD treatment. MATERIAL AND METHODS: A modified Delphi study was carried out by a panel of COPD management experts to evaluate suboptimal adherence. The Delphi questionnaire, completed in two rounds, comprised 84 statements across six domains: non-adherence, its impact, contributing factors, assessment methods, improvement strategies, and prioritization. Agreement was rated using a 9-point Likert scale and consensus considered as ≥70% agreement. RESULTS: Seventy-three multidisciplinary experts completed the questionnaire, reaching consensus on 74 of 84 statements. The panel identified high-impact, easy-to-implement interventions, culminating in a practical decalogue for optimizing inhalation therapy. Two key strategies were emphasized: simplifying and unifying inhalation regimens, and empowering patients. While all adherence assessment tools were considered useful, only digital and automated methods were deemed feasible in routine practice. Treatment optimization was also associated with reducing inhalation frequency by using long-acting molecules, and tailoring device selection to patient capacity. CONCLUSION: The resulting decalogue provides structured expert guidance for healthcare professionals, highlighting once-daily dosing, simplified devices, and patient engagement as the interventions considered most likely to improve adherence in COPD.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。